Viewing StudyNCT05561751



Ignite Creation Date: 2024-05-06 @ 6:09 PM
Last Modification Date: 2024-10-26 @ 2:42 PM
Study NCT ID: NCT05561751
Status: RECRUITING
Last Update Posted: 2024-04-26
First Post: 2022-09-26

Brief Title: Ph2 Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Sponsor:
Organization: GPCR Therapeutics Inc

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 40
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: